Hormonal and neural control of insulin secretion following gastric bypass surgery

胃绕道手术后胰岛素分泌的激素和神经控制

• 批准号: 8081759
• 负责人: Marzieh Salehi
• 金额: $ 17.77万
• 依托单位: UNIVERSITY OF CINCINNATI
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8081759
• 关键词: Address; Affect; Area; Bariatrics; Beta Cell; Body Weight decreased; C-Peptide; Cell physiology; Cells; Clinical; Complication; Consumption; Control Groups; Development; Diabetes Mellitus; Diffuse; Distal; Dose; Endocrine; Euglycemic Clamping; Food; Gastric Bypass; Gastrointestinal Hormones; Glucagon; Glucose; Glucose Clamp; Goals; Growth; Health; Histology; Hormonal; Hormones; Hyperglycemia; Hyperinsulinism; Hyperplasia; Hypoglycemia; Individual; Ingestion; Insulin; Islet Cell; Laboratory Research; Lead; Learning; Life; Limb structure; Measures; Mediating; Medical; Mentorship; Metabolic; Modification; Neuraxis; Non-Insulin-Dependent Diabetes Mellitus; Nutrient; Obesity; Operative Surgical Procedures; Oral; Pancreas; Pancreatectomy; Pancreatic Polypeptide; Parasympathetic Nervous System; Patients; Persons; Phenotype; Physiological; Plasma; Population; Principal Investigator; Procedures; Process; Regulation; Reporting; Research; Research Methodology; Research Personnel; Resolution; Risk; Role; Signal Transduction; Small Intestines; Stimulus; Stomach; Subgroup; Syndrome; Techniques; Testing; Time; Training; Training Programs; Up-Regulation; bariatric surgery; blood glucose regulation; career; cholinergic; design; diabetic patient; gastrointestinal; glucagon-like peptide; glucose metabolism; glucose tolerance; improved; insight; insulin secretion; insulinoma; interest; islet; neural stimulation; neuroregulation; novel therapeutics; obesity treatment; receptor; relating to nervous system; response; sham feeding; skills; visceral afferent nerve

DESCRIPTION (provided by applicant): This application is to provide the candidate with scholarly training, mentorship, and protected time with the goal of becoming an independent clinical researcher. Dr. Salehi will study the functions of gastrointestinal (Gl) hormones and neural signaling in glucose metabolism by focusing on the physiologic changes following Roux-en-Y gastric bypass (RYGB). RYGB has been reported to reverse type 2 diabetes (T2DM) immediately after surgery before any significant weight loss. In addition, a growing number of patients have been recognized with life-threatening hyperinsulinemic hypoglycemia several years following their surgery. These findings suggest that the RYGB procedure alters the regulation of (-cell function to promote insulin secretion. While the mechanisms by which RYGB improves glucose metabolism or alters islet cell function in patients after RYGB are not understood, recent studies suggest that increased secretion of Gl hormones, primarily glucagon-like peptide 1 (GLP-1), may contribute to enhanced insulin secretion in general, and to a greater extent in patients with hypoglycemia. However, there is also reason to suspect that changes in neural signaling may influence islet cell function in concert with Gl hormones after RYGB, since these patients have an earlier insulin peak and a larger glucagon secretion in response to food ingestion. The proposed research is designed to address the role of RYGB on insulin secretion by determining 1) the contribution of stimulatory factors (neural and Gl hormone) on islet cell function; and 2) the islet cell responsiveness to the physiologic stimulatory factors, in RYGB patients with and without hypoglycemia and non-operated controls. The first goal will be achieved by comparing the effects of cholinergic or GLP-1 blockade on the release of postprandial islet hormones. The second goal will be accomplished by measuring beta-cell responsiveness to exogenous GLP-1, sham feeing, or oral glucose ingestion. To achieve her career objectives, the candidate proposes a five-year training program to learn skills in laboratory research methods, statistical analysis, and islet cell physiologic studies focusing on the role of Gl hormones and neural regulatory factors. Her primary sponsor is highly accomplished investigator in glucose metabolism and Gl hormones and the secondary sponsor in neural signaling and islet cell physiology. Understanding the physiologic mechanisms whereby RYGB influences islet cell function, both improving glucose metabolism and causing hypoglycemic syndrome can lead to the development of new therapeutic options for T2DM as well as surgical refinements or medical therapies for those patients who develop hypoglycemia. PUBLIC HEALTH RELEVANCE: Better understanding of metabolic consequences of RYGB is critical given the rising use of gastric bypass surgeries due to dramatic increase of obesity in the population. The results of this project will provide insights to apply to treatment of diabetes as well as modification of bariatric techniques to reduce the late-complications of hypoglycemia in the groups of patients at risk.

描述（由申请人提供）：